Current Cancer patients News and Events

Current Cancer patients News and Events, Cancer patients News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 25 | 1000 Results
Better survival among women after lung cancer surgery
There are known differences in the survival rates of women and men with lung cancer. Researchers at Karolinska Institutet in Sweden set out to investigate potential reasons behind this disparity, such as the presence of other underlying diseases and smoking status. The study, which was published in Chest, shows that women have better survival rates after lung cancer surgery than men, independent of other factors. (2020-11-23)

New type of immunotherapy may pave the way for better cancer treatments
Immunotherapy for cancer has made great advances and many patients can now receive effective treatments that were not available ten years ago. However, there are certain types of cancer that do not respond to existing immunotherapy. A study from Karolinska Institutet in Sweden published in Proceedings of the National Academy of Sciences (PNAS) reports on a new kind of immunotherapy that gives hope of more treatment options for cancer in the future. (2020-11-23)

Study of 'exceptional responders' yields clues to cancer and potential treatments
In a comprehensive analysis of patients with cancer who had exceptional responses to therapy, researchers have identified molecular changes in the patients' tumors that may explain some of the exceptional responses. The results demonstrate that genomic characterizations of cancer can uncover genetic alterations that may contribute to unexpected and long-lasting responses to treatment, according to the researchers. The results appeared in Cancer Cell on Nov. 19, 2020. (2020-11-19)

Frozen eggs and ovarian tissue helped women conceive children after breast cancer
Women with breast cancer whose eggs or ovarian tissue were frozen had more children after their diagnosis than women who did not undergo fertility preservation using those methods before start of cancer treatment. That is according to a study by researchers at Karolinska Institutet in Sweden that is published in the journal JAMA Oncology. According to the researchers, the result highlights the importance of reproductive counseling and fertility preservation for women who are diagnosed with cancer at a young age. (2020-11-19)

Brain protein could be starting point for new treatments for pancreatic cancer
Researchers have discovered that a protein thought to only be involved in the development of neurons in the brain also plays a major role in the development and growth of pancreatic cancer. Their findings demonstrate for the first time how the protein, called Netrin-G1, helps pancreatic cancer cells survive by protecting them from the immune system and supplying them with nutrients. (2020-11-18)

Patients strongly favor banning bacon in hospitals, according to new survey
Most hospitalized patients favor eliminating processed meats--including bacon, deli meat, and sausage--from hospital menus to reduce cancer risk, according to a new survey published in the Journal of Hospital Management and Health Policy. (2020-11-18)

Existing antidepressant helps to inhibit growth of cancer cells in lab animals
New research has shown that the antidepressant sertraline helps to inhibit the growth of cancer cells. The substance acts on a metabolic addiction that allows different types of cancer to grow. This is shown by a study on cell cultures and lab animals by researchers at KU Leuven. (2020-11-17)

Common prostate cancer treatment may impair cardiorespiratory fitness, raise risk of CV death
Prolonged androgen deprivation therapy (ADT) can impair cardiorespiratory fitness and increase risk of cardiovascular death in prostate cancer patients with high risk of cardiovascular disease, according to a study in JACC: CardioOncology. The findings contribute further data supporting the need for cardiovascular disease (CVD) monitoring in patients who are living longer after successful cancer treatment. (2020-11-17)

Study identifies patients with lung cancer most likely to respond to immunotherapy
In a new study, researchers at UCLA found patients with a particular type of HLA, a protein scaffold involved in presenting pieces of proteins described as peptides to the immune system, were particularly likely to benefit from immunotherapy. (2020-11-16)

Researchers discover how to boost vaccine designed to prevent melanoma recurrence
A vaccine created to prevent the recurrence of the deadly skin cancer melanoma is about twice as effective when patients also receive two components that boost the number and effectiveness of immune system cells called dendritic cells, according to phase 2 clinical trial results published in Nature Cancer in November. (2020-11-16)

Singapore scientists identify potential new biomarker to better personalize cancer therapy
Testing for mutations in RNF43, a protein that affects key cancer cell-growth pathway Wnt, gives clinicians actionable insights to tailor treatments better. (2020-11-13)

Rare angiosarcoma tumors respond well to immunotherapy combination
Researchers from SWOG Cancer Research Network, a cancer clinical trials group funded by the National Cancer Institute's (NCI) Division of Cancer Diagnosis and Treatment (DCTD), part of the National Institutes of Health, have shown that the immunotherapy combination of ipilimumab and nivolumab shrinks rare angiosarcoma tumors in 25 percent of all patients, with some having an even stronger response to the drug combination. (2020-11-13)

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden. (2020-11-12)

Nearly 1 in 5 cancer patients less likely to enroll in clinical trials during pandemic
A significant portion of cancer patients may be less likely to enroll in a clinical trial due to the ongoing coronavirus pandemic. (2020-11-12)

Personalized cancer vaccine clinical trial to expand following promising early results
A University of Arizona Health Sciences clinical trial to study safety and effectiveness of a personalized cancer vaccine combined with immunotherapy drug Pembrolizumab will expand after promising preliminary data was presented at the Society for the Immunotherapy of Cancer's annual meeting. Researcher Julie E. Bauman, MD, MPH, reported data on the first 10 patients with head and neck cancer, seven of whom were treated at Banner - University Medicine, clinical partner for the UArizona Cancer Center. (2020-11-10)

Racial/ethnic minorities comprise small portion of patients referred with AL amyloidosis
Despite being theoretically at an increased risk for AL amyloidosis, underrepresented minorities make up only a small percentage of patients seen at specialized treatment centers for this disease. (2020-11-10)

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening. Researchers at the University of Georgia analyzed the health outcomes of 90,275 patients, comparing those who were screened versus those who received usual medical care or chest x-rays. (2020-11-10)

New cancer drugs saved over 1.2 million people in the US over 16 years, new study shows
More than 1.2 million people in the US prevented facing death following a cancer diagnosis, between the year 2000 and 2016, thanks to ever improving treatment options -- a large new national study shows. (2020-11-09)

Young survivors of acute myeloid leukemia have long-term complications from treatment
Adolescent and young adult (AYA) patients treated for acute myeloid leukemia (AML) have a high risk of developing several long-term health complications after treatment, a study led by UC Davis Comprehensive Cancer Center researchers has found. The most common complications were cardiovascular, endocrine and respiratory diseases. The complications - known as late effects - were more present among non-white AYA patients and those living in more deprived neighborhoods. (2020-11-09)

Medicaid expansion linked to lower mortality rates for three major types of cancer
In states that have expanded Medicaid availability as part of the Affordable Care Act (ACA), mortality rates for three major forms of cancer are significantly lower than in states that have not expanded their Medicaid, a new study by researchers at Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard University shows (2020-11-05)

Blood cell mutations confound prostate cancer liquid biopsy results
Unrelated mutations, when present in the blood, can give false positive results in men with advanced prostate cancer undergoing liquid biopsies. Such tests, which look for variants in cell-free DNA that tumors shed into the blood plasma, help determine suitable treatment options. Incorrect test results might mean the patient gets therapies unsuited for his cancer. A simple solution overcomes this problem. (2020-11-05)

Immunotherapy may work better in stomach cancer when combined with chemo, given earlier
Immunotherapy, often ineffective against stomach cancer, was more effective when combined with chemotherapy and given earlier, finds a new study in mice. (2020-11-05)

Every month delayed in cancer treatment can raise risk of death by around 10%
People whose treatment for cancer is delayed by even one month have in many cases a 6 to 13% higher risk of dying - a risk that keeps rising the longer their treatment does not begin - suggests research published online in The BMJ. (2020-11-04)

Active surveillance safe for African Americans with low-risk prostate cancer
Researchers with UC San Diego School of Medicine and Moores Cancer Center say active surveillance is safe for African American men with low-risk prostate cancer. (2020-11-03)

Mayo Clinic study finds 1 in 8 patients with cancer harbor inherited genetic mutations
PHOENIX, Ariz. ? Genetic testing can uncover inherited genetic mutations, and could individualize cancer therapies, improve survival, manage cancer in loved ones and push the boundaries of precision medicine. (2020-11-02)

Immunotherapy side effect could be a positive sign for kidney cancer patients
An autoimmune side effect of immune checkpoint inhibitor (ICI) drugs could signal improved control of kidney cancer, according to a new study by researchers in UT Southwestern's Kidney Cancer Program (KCP). (2020-11-02)

Cancer treatment could be replicated for COVID-19
Beta-blockers could potentially be used to treat COVID-19, according to a new international study by Italian and Australian scientists. (2020-11-02)

Machine learning that predicts anti-cancer drug efficacy
Research on anti-cancer drug response in patient-derived artificial organoids and transcriptome learning of genes associated with anti-cancer target proteins. (2020-11-01)

Skilled surgeons boost colon cancer survival by 70%
Patients of more technically skilled surgeons, as assessed by review of operative video, have better long-term survival after surgery for the treatment of colon cancer, reports a new study. Patients whose surgery was performed by a highly skilled surgeon had a 70 percent lower risk of dying over five years compared to patients with a lower skilled surgeon. (2020-10-30)

Giving the immune system a double boost against cancer
Cancer immunotherapies are very effective for some patients, but many cancers do not respond to the currently available treatments. Researchers are developing a new approach that expands the number of treatable tumor types. (2020-10-30)

Changes in subcellular traffic increase invasiveness of radioresistant cancer cells
Scientists have revealed the molecular mechanism regulating the trafficking of lysosomes that increases the invasiveness of radioresistant cancer cells following radiotherapy. (2020-10-29)

Study reveals impact of COVID-19 on oncology staff and their work
A study presented at the NCRI Virtual Showcase reports the results of a survey of oncology staff on their management of patients, their wellbeing and whether they felt valued during the first wave of the COVID-19 pandemic. (2020-10-29)

Greater prostate cancer incidence; mortality among Black men linked to genetic alterations
Prostate cancer tumors from African American men had higher frequencies of certain genetic alterations that may be associated with aggressive disease, compared with prostate cancer tumors from white men. (2020-10-28)

Researchers find source of breast tumor heterogeneity and pathway that limits emergence
A team of researchers led by Dartmouth's and Dartmouth-Hitchcock's Norris Cotton Cancer Center has identified mammary basal cells as a contributing source to the development of heterogeneous tumor cell subpopulations and found that activation of the PKA signaling pathway can curtail their emergence, providing opportunities for new therapeutic approaches to breast cancer. (2020-10-28)

Racial disparities in treatment for common lung cancer persist despite gains
African American patients with lung cancer are still less likely to receive the most effective treatment for a common type of early stage lung cancer. (2020-10-28)

18F-Fluciclovine PET/MRI for prostate cancer staging, androgen deprivation evaluation
According to an open-access article in ARRS' American Journal of Roentgenology, fluorine-18-labeled fluciclovine PET/MRI demonstrated utility in the initial staging of high-risk prostate cancer, as well as for evaluating the response to androgen deprivation therapy. Given the FDA approval and widespread availability of 18F-fluciclovine, the findings could have impact in the immediate future in guiding initial management of patients with prostate cancer. (2020-10-27)

Low quantity and quality of muscle predicts poor outcomes in colon cancer surgery
New study suggests interventions to help patients build muscle before surgery may improve their outcomes (2020-10-27)

Liver cancer diagnoses and deaths impacted by geography and household income
An analysis of information from a large U.S. cancer database indicates that patients with liver cancer from rural regions and lower income households often have more advanced cancer at the time of diagnosis and face a higher risk of death compared with other patients. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society (ACS). (2020-10-26)

Taking the itch out of cancer immunotherapy
Researchers from the University of Tsukuba have determined that PD-1 expression on CD8 T cells is the biological pathway that leads to psoriasis-like dermatitis, an unfavorable side effect of cancer immunotherapy with PD-1 inhibitors. This finding offers hope that blocking this pathway can prevent or reduce the undesirable side effect and help cancer patients continue their treatment with improved quality-of-life. (2020-10-26)

Study shows how exercise stalls cancer growth through the immune system
People with cancer who exercise generally have a better prognosis than inactive patients. Now, researchers at Karolinska Institutet in Sweden have found a likely explanation of why exercise helps slow down cancer growth in mice: Physical activity changes the metabolism of the immune system's cytotoxic T cells and thereby improves their ability to attack cancer cells. The study is published in the journal eLife. (2020-10-26)

Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.